Services Offered
Assessments,
Individual Counseling,
and Group Counseling​
Medication Assisted Treatment (Methadone and Suboxone)
and Drug Screening​
Referrals,
Community Supports,
and Community Resources
Located in Louisville, KY, Renewed Beginnings Clinic is a dedicated facility committed to transforming lives and offering hope to individuals battling addiction. We provide state-of-the-art services tailored to meet the unique needs of each person on their journey to recovery.
Rooted in the principles of harm reduction, our comprehensive approach integrates medication-assisted treatment (MAT), individual and group therapy, psychiatric care, and peer support to promote long-term success and wellness.
​
Our full spectrum of services includes:
-
Outpatient addiction treatment
-
Medication management
-
Evidence-based counseling modalities
-
Aftercare planning and support
-
Educational resources for patients and families​
​
At Renewed Beginnings, we meet patients where they are—with respect, compassion, and the tools needed for lasting recovery.
Methadone is a medication used to treat Opioid Use Disorder (OUD). Methadone, a long-acting opioid agonist, reduces opioid craving and withdrawal and blunts or blocks the effects of opioids. Taken daily, it is available in liquid, powder and diskettes forms. Patients taking methadone to treat OUD must receive the medication under the supervision of a practitioner. After a period of stability (based on progress and proven, consistent compliance with the medication dosage), patients may be allowed to take methadone at home between program visits. The length of time a person receives methadone treatment varies. Methadone is safe and effective, when taken as prescribed. Methadone medication is specifically tailored for the individual patient (and doses are often adjusted and readjusted).
Suboxone (Buprenorphine/naloxone sublingual films) is an opioid partial agonist. It produces effects such as euphoria or respiratory depression at low to moderate doses. With buprenorphine, however, these effects are weaker than full opioid agonists such as methadone and heroin. To begin treatment, an OUD patient must abstain from using opioids for at least 12 to 24 hours and be in the early stages of opioid withdrawal. Patents with opioids in their bloodstream or who are not in the early stages of withdrawal, may experience acute withdrawal. The length of time a patient receives buprenorphine is tailored to meet the needs of each patient, and in some cases, treatment can be indefinite. When taken as prescribed, buprenorphine is safe and effective.